Araştırma Çıktıları

Permanent URI for this communityhttps://hdl.handle.net/11443/931

Browse

Author: search.filters.author.Griffiths, MartinSubject: search.filters.subject.randomized controlled trial

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Assessing Feasibility and Acceptability of Web-Based Enhanced Relapse Prevention for Bipolar Disorder (ERPonline): A Randomized Controlled Trial
    (JMIR PUBLICATIONS, INC, 2017-01-01) Lobban, Fiona; Dodd, Alyson L.; Sawczuk, Adam P.; Asar, Ozgur; Dagnan, Dave; Diggle, Peter J.; Griffiths, Martin; Honary, Mahsa; Knowles, Dawn; Long, Rita; Morriss, Richard; Parker, Rob; Jones, Steven
    Background Interventions that teach people with bipolar disorder (BD) to recognize and respond to early warning signs (EWS) of relapse are recommended but implementation in clinical practice is poor. Objectives The objective of this study was to test the feasibility and acceptability of a randomized controlled trial (RCT) to evaluate a Web-based enhanced relapse prevention intervention (ERPonline) and to report preliminary evidence of effectiveness. Methods A single-blind, parallel, primarily online RCT (n=96) over 48 weeks comparing ERPonline plus usual treatment with ``waitlist (WL) control{''} plus usual treatment for people with BD recruited through National Health Services (NHSs), voluntary organizations, and media. Randomization was independent, minimized on number of previous episodes (<8, 8-20, 21+). Primary outcomes were recruitment and retention rates, levels of intervention use, adverse events, and participant feedback. Process and clinical outcomes were assessed by telephone and Web and compared using linear models with intention-to-treat analysis. Results A total of 280 people registered interest online, from which 96 met inclusion criteria, consented, and were randomized (49 to WL, 47 to ERPonline) over 17 months, with 80\% retention in telephone and online follow-up at all time points, except at week 48 (76\%). Acceptability was high for both ERPonline and trial methods. ERPonline cost approximately 19,340 to create, and 2176 per year to host and maintain the site. Qualitative data highlighted the importance of the relationship that the users have with Web-based interventions. Differences between the group means suggested that access to ERPonline was associated with: a more positive model of BD at 24 weeks (10.70, 95\% CI 0.90 to 20.5) and 48 weeks (13.1, 95\% CI 2.44 to 23.93)